Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
Boiron | 0220-9077 | TOPICAL | 1 [hp_X] in 1 g | 5/12/2025 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
Nature's Sunshine Anti-Inflam | 26083 | Medicine | A | 10/15/1991 | |
Tregocel | 434012 | Pharmametics Products A Division of Max Biocare Pty Ltd | Medicine | A | 1/16/2024 |
PainPlex | 422037 | Medicine | A | 9/19/2023 | |
Blackmores Back Formula | 159990 | Medicine | A | 3/10/2009 | |
InflamAid Plus | 445711 | Medicine | A | 4/12/2024 | |
GO TURMERIC JOINT PAIN RELIEF 1-A-DAY | 356580 | Medicine | A | 3/11/2021 | |
METAGENICS JOINT SUSTAINED CARE | 472830 | Medicine | A | 12/12/2024 | |
Painlys | 397149 | Medicine | A | 10/6/2022 | |
PainGo | 382518 | G & W Aust Pty Ltd | Medicine | A | 1/12/2022 |
InflamAid Plus | 388181 | Medicine | A | 5/9/2022 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
HARPAGOPHYTUM PROCUMBENS GOUTTE 4CH-30CH | dolisos laboratoires s.a. | 00693308 | Drops - Oral | 1 DH / DH | 12/31/1987 |
SPON-BOSAN B65 - ONT | professional health products | 02175274 | Ointment - Topical | 1 D / D | 12/31/1996 |
FORMULA D/W COMBINATION-CAPLET | health-wise nutrition inc. | 02200171 | Tablet - Oral | 100 MG | 11/11/1996 |
AR-ENCAP | thorne research canada ltd. | 02239529 | Capsule - Oral | 200 MG / CAP | N/A |
HARPAGOPHYTUM PROCUMBENS | seroyal international inc. | 02233756 | Granules
,
Drops
,
Capsule
,
Tablet
,
Liquid
,
Globules
,
Pellet
,
Powder - Oral | 2 X | 4/6/1998 |
NOVAPLEX I | bio active canada ltd. | 02234242 | Liquid - Oral | 2 X | 5/26/1998 |
HARPAGOPHYTUM PROCUMBENS | dolisos canada inc. | 02236470 | Granules
,
Liquid
,
Globules - Oral | 2 X | 1/5/1998 |
ETHICAL HERBALS DEVIL'S CLAW | ashbury research corporation | 02240952 | Tablet - Oral | 150 MG / TAB | N/A |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
HARPAGOFITO ARKOPHARMA CÁPSULAS DURAS | Arkopharma Laboratorios S.A.U. | 72529 | CÁPSULA DURA | Sin Receta | Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.